Bath Savings Trust Co Purchases 7,917 Shares of Colgate-Palmolive Company $CL

Bath Savings Trust Co raised its position in shares of Colgate-Palmolive Company (NYSE:CL) by 9.9% in the 3rd quarter, Holdings Channel reports. The firm owned 88,211 shares of the company’s stock after acquiring an additional 7,917 shares during the period. Bath Savings Trust Co’s holdings in Colgate-Palmolive were worth $7,052,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. Westside Investment Management Inc. boosted its position in Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after buying an additional 130 shares in the last quarter. Saudi Central Bank acquired a new position in Colgate-Palmolive during the 1st quarter worth about $29,000. Vermillion & White Wealth Management Group LLC boosted its holdings in Colgate-Palmolive by 86.1% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after acquiring an additional 155 shares during the last quarter. Ransom Advisory Ltd bought a new stake in shares of Colgate-Palmolive in the 1st quarter valued at $33,000. Finally, MTM Investment Management LLC acquired a new stake in Colgate-Palmolive during the 2nd quarter worth about $39,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock opened at $77.73 on Friday. The company has a current ratio of 0.93, a quick ratio of 0.60 and a debt-to-equity ratio of 5.90. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18. The firm has a market capitalization of $62.66 billion, a PE ratio of 21.77, a price-to-earnings-growth ratio of 5.68 and a beta of 0.30. The firm’s 50 day simple moving average is $78.31 and its 200 day simple moving average is $83.22.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, October 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.89 by $0.02. The business had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.17 billion. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.The firm’s revenue was up 1.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.91 earnings per share. As a group, analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st will be given a dividend of $0.52 per share. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 annualized dividend and a dividend yield of 2.7%. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.26%.

Analyst Upgrades and Downgrades

Several analysts have recently commented on CL shares. Deutsche Bank Aktiengesellschaft set a $86.00 price objective on shares of Colgate-Palmolive in a research report on Friday, October 10th. Royal Bank Of Canada raised Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective for the company in a research note on Tuesday, December 9th. Argus restated a “hold” rating on shares of Colgate-Palmolive in a report on Thursday, December 11th. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, October 8th. Finally, Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating for the company in a research report on Monday, November 3rd. Ten research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $88.81.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.